Literature DB >> 15378033

The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.

Andrea Pichler1, Puck Knipscheer, Hisato Saitoh, Titia K Sixma, Frauke Melchior.   

Abstract

Post-translational modification with the ubiquitin-related protein SUMO1 requires the E1 enzyme Aos1-Uba2 and the E2 enzyme Ubc9. Distinct E3 ligases strongly enhance modification of specific targets. The SUMO E3 ligase RanBP2 (also known as Nup358) has no obvious similarity to RING- or HECT-type enzymes. Here we show that RanBP2's 30-kDa catalytic fragment is a largely unstructured protein. Despite two distinct but partially overlapping 79-residue catalytic domains, one of which is sufficient for maximal activity, RanBP2 binds to Ubc9 in a 1:1 stoichiometry. The identification of nine RanBP2 and three Ubc9 side chains that are important for RanBP2-dependent SUMOylation indicates largely hydrophobic interactions. These properties distinguish RanBP2 from all other known E3 ligases, and we speculate that RanBP2 exerts its catalytic effect by altering Ubc9's properties rather than by mediating target interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378033     DOI: 10.1038/nsmb834

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  58 in total

1.  Targeting zinc finger domains with small molecules: solution structure and binding studies of the RanBP2-type zinc finger of RBM5.

Authors:  Biancamaria Farina; Roberto Fattorusso; Maurizio Pellecchia
Journal:  Chembiochem       Date:  2011-12-16       Impact factor: 3.164

2.  Insights into ubiquitin-conjugating enzyme/ co-activator interactions from the structure of the Pex4p:Pex22p complex.

Authors:  Chris Williams; Marlene van den Berg; Santosh Panjikar; Will A Stanley; Ben Distel; Matthias Wilmanns
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

3.  CD2AP regulates SUMOylation of CIN85 in podocytes.

Authors:  Irini Tossidou; Rainer Niedenthal; Malte Klaus; Beina Teng; Kirstin Worthmann; Benjamin L King; Kevin J Peterson; Hermann Haller; Mario Schiffer
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

4.  Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.

Authors:  Hyunju Ryu; Yoshiaki Azuma
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

Review 5.  SUMO wrestling with type 1 diabetes.

Authors:  Manyu Li; Dehuang Guo; Carlos M Isales; Decio L Eizirik; Mark Atkinson; Jin-Xiong She; Cong-Yi Wang
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

6.  Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress.

Authors:  Robert C A M van Waardenburg; David M Duda; Cynthia S Lancaster; Brenda A Schulman; Mary-Ann Bjornsti
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 7.  Taking it step by step: mechanistic insights from structural studies of ubiquitin/ubiquitin-like protein modification pathways.

Authors:  Allan D Capili; Christopher D Lima
Journal:  Curr Opin Struct Biol       Date:  2007-10-04       Impact factor: 6.809

Review 8.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

Review 9.  Structural and functional insights to ubiquitin-like protein conjugation.

Authors:  Frederick C Streich; Christopher D Lima
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

10.  Up-regulation of SUMO E3 ligases during lung schistosomula and adult worm stages.

Authors:  Roberta V Pereira; Matheus de S Gomes; Fernanda Janku Cabral; Liana K Jannotti-Passos; Vanderlei Rodrigues; William de Castro-Borges; Renata Guerra-Sá
Journal:  Parasitol Res       Date:  2014-05-07       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.